a stable vincristine ( vcr ) -resistant variant ( k562/vcr ) was established from human myelogenous leukemia k562 by continuous exposure of the cells with increasing concentration of vcr up to 30 nm , followed by the maintenance of the cells in the presence of 30 nm of vcr for 6 months .
C0007634
cells
C1516348
maintenance